| TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia S Claudiani, JF Apperley, R Szydlo, A Khan, G Nesr, C Hayden, A J Innes, ... British Journal of Haematology 193 (2), 346-355, 2021 | 31 | 2021 |
| Immune thrombocytopenia flare with mild COVID‐19 infection in pregnancy: A case report G Nesr, C Garnett, C Bailey, R Koshy, S Arami British Journal of Haematology 190 (3), e146, 2020 | 18 | 2020 |
| MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia S Claudiani, A Gatenby, R Szydlo, G Nesr, AS Abulafia, ... haematologica 104 (11), 2206, 2019 | 14 | 2019 |
| Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report. G Nesr, R Koshy, D Foldes, H Kagdi | 12 | 2020 |
| Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom C Garnett, D Foldes, C Bailey, G Nesr, T Hui, R Hinton, K Gurung, ... Leukemia & Lymphoma 62 (2), 469-472, 2021 | 8 | 2021 |
| Outcome of COVID‐19 in patients with chronic myeloid leukemia: A single centre UK experience. G Nesr, Z Saleem, S Arami Journal of Medical Virology 94 (4), 2022 | 4 | 2022 |
| Dose reduction of first and second generation TKIs is effective in the maintenance of major molecular response and may predict successful Tfr in CML patients S Claudiani, J Apperley, A Khan, R Szydlo, G Nesr, G Adams, L Foroni, ... Blood 132, 3007, 2018 | 4 | 2018 |
| Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia G Nesr, S Claudiani, D Milojkovic, A Innes, F Fernando, I Caballes, ... Leukemia & Lymphoma, 1-6, 2024 | 3 | 2024 |
| Changes in RT-qPCR levels during and after TKI interruptions for attempted conceptions in women with CML L Caldwell, S Claudiani, D Milojkovic, R Szydlo, E Abruzzese, G Nesr, ... Blood 130, 1612, 2017 | 3 | 2017 |
| Platelet function in patients with chronic myeloid leukemia treated with asciminib G Nesr, M Laffan, S Claudiani, A Innes, J Apperley, D Milojkovic Leukemia & Lymphoma 61 (12), 3021-3023, 2020 | 2 | 2020 |
| P714: Effect of Tyrosine Kinase Inhibitors on Male Fertility in Patients With Chronic Phase Chronic Myeloid Leukaemia G Nesr, S Claudiani, D Milojkovic, I Caballes, S Lovato, J Channa, ... HemaSphere 6, 609-610, 2022 | 1 | 2022 |
| Plasma cell leukaemia with" lymphoid‐like morphology" in peripheral blood. G Nesr, R Maniusyte, A Dunlop, H Kagdi International Journal of Laboratory Hematology 44 (1), 2022 | 1 | 2022 |
| Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust R Hinton, G Nesr, C Garnett, D Foldes, JJR McCay, R Medland, H Kagdi, ... Leukemia & Lymphoma 63 (1), 227-230, 2022 | 1 | 2022 |
| The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: A case series of 3 patients G Nesr, S Claudiani, J Khorashad, J Apperley, D Milojkovic Leukemia & Lymphoma 60 (13), 3333-3334, 2019 | 1 | 2019 |
| First report from the UK National Registry for chronic myeloid leukaemia: analysis of baseline characteristics of 435 patients GNG Nesr, R Szydlo, B Braithwaite, S Frackleton, J Apperley, D Milojkovic, ... British Journal of Haematology 181, 48-48, 2018 | 1 | 2018 |
| Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience D Melotti, S Asher, E Troy‐Barnes, G Nesr, W Wilson, M Camilleri, ... EJHaem 5 (5), 1102-1106, 2024 | | 2024 |
| Haematopoietic stem cell mobilisation followed by high‐dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma. S Asher, R Shah, S Ings, J Horder, F Newrick, G Nesr, R Kesse Adu, ... British Journal of Haematology 202 (6), 2023 | | 2023 |
| Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience G Nesr, R Shah, C Kyriakou, J Sive, R Popat, K Yong, B Wisniowski, K Xu, ... Leukemia & Lymphoma 64 (8), 1465-1471, 2023 | | 2023 |
| Impact of timing of stem cell return following high-dose melphalan in myeloma patients with renal impairment G Nesr, N Rabin, C Kyriakou, J Sive, R Popat, K Yong, B Wisniowski, K Xu, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 323-323, 2022 | | 2022 |
| P713: REAL-WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML G Nesr, R Szydlo, B Braithwaite, S Frackelton, P Mathew, M Hashmi, ... HemaSphere 6, 608-609, 2022 | | 2022 |
apperley jProfessor of Hemato-oncology, Imperial CollegeVerified email at imperial.ac.uk
